TMates vs RxActivate: flat-rate semaglutide vs gated pricing

TMates vs RxActivate: TMates offers a flat $199/month semaglutide program with 24/7 U.S. doctor access and the same price at every dose; RxActivate requires a two-minute eligibility questionnaire and hides plan pricing behind contact submission. Early verdict: pick TMates for transparent flat pricing and continuous physician access, and pick RxActivate if you prefer clinician-matched plans and want eligibility screening before price disclosure.

See TMates semaglutide pricing and details

Quick comparison: how TMates and RxActivate differ

This direct comparison highlights the most distinctive differences between TMates and RxActivate using only supplied facts: pricing transparency and structure, physician access model, intake and eligibility flow, medication type and sourcing notes, and state or service gating.

1. Pricing transparency and structure

TMates publishes a flat $199/month price and emphasizes the same price at all doses with no step-up fees as dosage escalates. TMates notes other listed price points for multi-month packages but its core claim is a flat $199/month at every dose. By contrast, RxActivate does not display price before the contact-information gate: plan and price are revealed only after completing the eligibility questionnaire and submitting first name, last name, email and phone number. Pricing for RxActivate is therefore gated behind intake and not publicly visible on the captured landing flow.

2. Physician access and clinical model

TMates advertises 24/7 access to U.S.-based doctors across all 50 states and includes virtual check-ins as part of its doctor-supervised program. RxActivate describes a clinician-matched GLP-1 plan and state and medical-safety screening; treatment is available only when a licensed clinician determines it is medically appropriate. The supplied evidence frames TMates as continuous physician availability while RxActivate emphasizes clinician matching and safety screening prior to treatment.

Start RxActivate eligibility questionnaire

3. Intake flow and eligibility gating

RxActivate uses a two-minute eligibility questionnaire requesting goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening. The flow confirmed Alabama as serviceable in a synthetic test and then required contact information before revealing plan or price. TMates does not gate pricing behind a contact-information step according to the captured evidence; its pricing and program features are presented on the landing page.

4. Medication type, sourcing, and regulatory note

TMates offers clinically dosed compounded semaglutide formulated in U.S.-based facilities and states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. TMates notes it does not offer branded Ozempic, Wegovy, or Zepbound and highlights compounded semaglutide for dosage flexibility. RxActivate may offer branded or compounded products depending on clinician determination, and the captured evidence notes that when compounded medications are offered they are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Branded versus compounded availability and specific medications are not disclosed in RxActivate capture before intake.

5. State coverage and shipping information

TMates states licensed coverage in all 50 states and that it ships to most states, with availability based on medical eligibility. RxActivate confirmed serviceability in Alabama in a synthetic test and uses state screening during intake; the captured evidence does not list a full-state coverage map or shipping terms before the intake gate.

Comparison table: TMates vs RxActivate

Criteria	TMates	RxActivate
Pricing visibility	$199/month flat, same price at all doses	Price gated; revealed after eligibility and contact info
Starting price shown	$199/month	Unverified before intake
Physician access	24/7 U.S. doctor access, virtual check-ins	Clinician-matched plans, clinician determines appropriateness
Intake flow	Pricing and program details on landing page	Two-minute questionnaire; contact info required before price
Medication sourcing	Clinically dosed compounded semaglutide formulated in U.S. facilities	Medication type determined by clinician; compounded options not FDA-approved when offered
State coverage	Licensed coverage in all 50 states; ships to most states	State screening during intake; Alabama confirmed in synthetic test

Compare TMates program features

What is not supplied in the evidence

The captured evidence does not provide independent outcome data, a full branded-product availability list for RxActivate before intake, or full shipping and cancellation terms for RxActivate prior to contact information. Do not infer medication efficacy, exact branded availability, or final cost for RxActivate from the supplied capture.

Get TMates enrollment information

Conclusion: choose based on transparency and screening

TMates vs RxActivate summary: TMates is clear about a flat $199/month price at every dose, 24/7 U.S. doctor access, and U.S.-formulated compounded semaglutide. RxActivate prioritizes clinician matching and medical eligibility screening but gates pricing and plan details behind a two-minute intake and contact-information step. Choose based only on supplied facts below.

• Choose TMates if you want transparent flat pricing ($199/month) and continuous U.S. physician access across all 50 states.
• Choose RxActivate if you want clinician-matched GLP-1 plans and prefer eligibility and safety screening before learning plan details and pricing.

Begin RxActivate eligibility flow